Related Experiment Video
Updated: Mar 10, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice
Maik Dahlhoff1, Sukalp Muzumdar2, Matthias Schäfer2
1Institute of Molecular Animal Breeding and Biotechnology, Gene Center, LMU Munich, Munich, Germany.
Abstract:
Although the epidermal growth factor receptor has established roles in skin carcinogenesis, inflammation, and wound healing, the functions of the structurally related receptor ERBB2 in this tissue remain poorly explored. To assess the functions of ERBB2 in skin homeostasis, tumorigenesis, and wound healing, we employed keratin 5-directed, cre recombinase-mediated targeting of Erbb2 alleles in mice. Erbb2del mice, lacking ERBB2 specifically in keratinocytes, showed no noticeable spontaneous skin abnormalities. During early wound healing, the thickness and the number and proliferation rate of keratinocytes in the wound epithelium of Erbb2del mice were significantly reduced. Compared with control littermates, Erbb2del mice remained free of papillomas for a longer time and had significantly reduced tumor burden after application of the 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate multistage chemical carcinogenesis protocol. Furthermore, tumor cell proliferation was substantially reduced in Erbb2del mice, and loss of ERBB2 also decreased keratinocyte proliferation after 12-O-tetradecanoylphorbol-13-acetate application. Thus, ERBB2 is dispensable for the development and homeostasis of the epidermis and its appendages. However, reflecting its pro-proliferative role, ERBB2 is required for the normal healing of skin wounds and for the progression of tumors during skin chemical carcinogenesis in mice. Thus, ERBB2 may be a promising target for inhibiting human nonmelanoma skin cancer progression.
Insights
The study found that ERBB2 (ErbB2) is not essential for normal skin development but is crucial for wound healing and skin cancer progression in mice. Targeting ERBB2 may help inhibit nonmelanoma skin cancer.
Area of Science:
- Dermatology
- Oncology
- Molecular Biology
Background:
- Epidermal growth factor receptor (EGFR) is known to play roles in skin carcinogenesis and wound healing.
- The function of the related receptor ERBB2 in skin tissues is less understood.
- Investigating ERBB2's role is important for understanding skin homeostasis and disease.
Purpose of the Study:
- To investigate the role of ERBB2 in mouse skin homeostasis, wound healing, and chemical carcinogenesis.
- To determine if ERBB2 is essential for normal epidermal development and function.
- To explore ERBB2 as a potential therapeutic target for skin cancers.
Main Methods:
- Used keratin 5-directed, cre recombinase-mediated targeting to create Erbb2-deficient mice (Erbb2del) specifically in keratinocytes.
- Assessed skin abnormalities, wound healing responses, and tumor development following a chemical carcinogenesis protocol (7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate).
- Analyzed keratinocyte proliferation rates in both wound healing and chemically induced tumor models.
Main Results:
- Erbb2del mice showed no spontaneous skin abnormalities, indicating ERBB2 is dispensable for epidermal homeostasis.
- Wound healing was impaired in Erbb2del mice, with reduced epithelial thickness and keratinocyte proliferation.
- Erbb2del mice exhibited delayed papilloma formation and reduced tumor burden during chemical carcinogenesis, with decreased tumor cell proliferation.
- Loss of ERBB2 also reduced keratinocyte proliferation following 12-O-tetradecanoylphorbol-13-acetate application.
Conclusions:
- ERBB2 is not required for the development and maintenance of the epidermis and its appendages.
- ERBB2 plays a significant pro-proliferative role, essential for normal skin wound healing.
- ERBB2 is required for the progression of chemically induced skin tumors in mice, suggesting it as a potential therapeutic target for nonmelanoma skin cancer.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
